Glucose-Na-K Baxter (Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Glucose, Sodium Acetate Trihydr)

Glucose-Na-K Baxter is indicated for clinical situations that require rapid volume expansion and electrolyte repletion. It is commonly employed in the following contexts:

• Treatment of dehydration caused by gastrointestinal losses or inadequate oral intake.
• Support during surgery or invasive procedures to maintain intravascular volume.
• Management of electrolyte imbalances such as hypokalemia, hyponatremia, or hypomagnesemia.
• Provision of metabolic substrate (glucose) in patients unable to receive enteral nutrition.
• Adjunct therapy in critical care settings for patients with shock or sepsis.

Adverse reactions to Glucose-Na-K Baxter are generally related to its electrolyte composition and infusion characteristics.

Common

• Mild infusion site irritation or phlebitis.
• Transient hyperglycemia.
• Slight electrolyte shifts (e.g., mild hyperkalemia).
• Nausea or vomiting.
• Headache.
• Flushing or warmth at the infusion site.

Serious

• Severe hyperkalemia leading to cardiac arrhythmia.
• Hypermagnesemia causing respiratory depression.
• Anaphylactic or severe allergic reaction.
• Volume overload with pulmonary edema.
• Metabolic acidosis from acetate accumulation.
• Hemolysis due to rapid infusion rates.

When administering Glucose-Na-K Baxter, clinicians should observe several safety considerations. Proper patient assessment and monitoring are essential to minimize risks.

• Verify electrolyte levels and renal function before initiation.
• Adjust infusion rate to avoid rapid volume expansion.
• Monitor cardiac rhythm in patients at risk for hyperkalemia.
• Use caution in patients with heart failure or fluid overload.
• Assess for signs of allergic reaction during the first infusion.
• Ensure compatibility with other IV solutions and medications.
• Document infusion parameters and patient response accurately.

Glucose-Na-K Baxter may interact with other medications that affect electrolyte balance or fluid status. Awareness of these interactions helps prevent complications.

Avoid

• Concurrent administration of high-dose potassium supplements without monitoring.
• Use of other magnesium-containing IV solutions that could cause hypermagnesemia.
• Co‑infusion with acidic drugs that may precipitate salts.

Use with caution

• Loop diuretics, which can alter potassium and magnesium levels.
• ACE inhibitors or ARBs, which may increase serum potassium.
• Insulin therapy, which can shift glucose and potassium intracellularly.
• Blood transfusions, which may affect calcium and magnesium balance.